TY  - GEN
AU  - Marx,S O
AU  - Marks,A R
TI  - Bench to bedside: the development of rapamycin and its application to stent restenosis
SN  - 1524-4539
PY  - 2001///0913
KW  - Angioplasty, Balloon, Coronary
KW  - adverse effects
KW  - Animals
KW  - Calcineurin Inhibitors
KW  - Carrier Proteins
KW  - metabolism
KW  - Cell Cycle Proteins
KW  - Cell Division
KW  - drug effects
KW  - Cell Movement
KW  - Clinical Trials as Topic
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - surgery
KW  - Cyclin-Dependent Kinase Inhibitor p27
KW  - Down-Regulation
KW  - Graft Occlusion, Vascular
KW  - diagnosis
KW  - Humans
KW  - Hyperplasia
KW  - Macromolecular Substances
KW  - Phosphotransferases (Alcohol Group Acceptor)
KW  - Platelet Aggregation Inhibitors
KW  - therapeutic use
KW  - Signal Transduction
KW  - Sirolimus
KW  - Stents
KW  - TOR Serine-Threonine Kinases
KW  - Tacrolimus
KW  - pharmacology
KW  - Tacrolimus Binding Protein 1A
KW  - Ticlopidine
KW  - analogs & derivatives
KW  - Tumor Suppressor Proteins
KW  - Tunica Media
KW  - Vascular Patency
N1  - Publication Type: Editorial
UR  - https://doi.org/10.1161/01.cir.104.8.852
ER  -